SCHEDULE 13G
Statement of Beneficial Ownership
Xilio Therapeutics, Inc. Filed Acc 0001104659-26-128741
Stakes reported in this filing
| Reporting person | Shares | Of the class |
|---|---|---|
| ADAR1 Capital Management, LLC | 381,000 | 9.3% |
| Daniel Schneeberger | 381,000 | 9.3% |
Members of a group can each report the same shares, so these rows overlap and don't add up.
Stake history · largest stake in each 13D and 13G
Loading xslSCHEDULE_13G_X02/primary_doc.xml…